3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
18
Prostatic Neoplasms, Castration-Resistant
3
Neoplasm Metastasis
3
Non-metastatic Castration-resistant Prostate Cancer
2
Metastatic Castration Resistant Prostate Cancer
2
Sleep Initiation and Maintenance Disorders
1
Non-metastatic Prostate Cancer
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Fatigue
1
Epilepsy
1
Depression
1
Castration-resistant Prostate Cancer
1
Brain Diseases
1
Advanced Prostate Carcinoma
1
Interventions
enzalutamide
1
darolutamide
1
apalutamide
1
Docetaxel
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer
×
enzalutamide
×
Clear all
NCT05901649
2026-05-08
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
504 enrolled